Engineering trust into every batch we manufacture.
Imperion Biolabs is a Nagpur-headquartered pharmaceutical manufacturer focused on hormone and specialty therapeutics — built for licensed distributors, healthcare partners, and regulated export markets.
Nagpur, Maharashtra
WHO-GMP aligned manufacturing facility
A focused manufacturer, not a general-purpose pharmacy.
Imperion Biolabs was established with a narrow, deliberate focus: manufacture hormone and specialty pharmaceutical formulations to a single, consistent standard — regardless of which market they are destined for. That focus shapes everything from how we source active pharmaceutical ingredients to how we document every batch we release.
Operating out of our Nagpur, Maharashtra facility, our manufacturing lines cover both sterile injectable formulations and oral solid dosage forms, produced under aseptic, WHO-GMP aligned conditions. Every formulation is tested against its pharmacopoeial monograph — USP or BP — before release.
We work exclusively through licensed distributors, healthcare partners, and registered export channels. Imperion Biolabs does not sell or dispense medicines directly to consumers — our role is to manufacture to specification and support our partners with the documentation their markets require.
The principles behind every formulation.
Precision
Formulated and dosed to exact pharmacopoeial specification, batch after batch.
Purity
Rigorous raw-material qualification and in-process testing at every manufacturing stage.
Performance
Formulations engineered for predictable, well-characterised release profiles.
Compliance
Documentation and quality systems built around the standards our export markets require.
From raw material to release, in six controlled stages.
Raw material qualification
Active ingredients are sourced and qualified against pharmacopoeial identity and purity criteria before release to manufacturing.
Formulation
Sterile oil/aqueous solutions and oral solid dosage forms are compounded to validated formulae under controlled environmental conditions.
Aseptic manufacturing
Injectable lines are processed under aseptic, WHO-GMP aligned conditions, with in-process monitoring at every stage.
Quality testing
Every batch is assayed for identity, potency, and sterility (where applicable) against its USP/BP monograph before release.
Batch release & documentation
Approved batches are released with full batch records, certificates of analysis, and manufacturer documentation.
Export & logistics
Shipments are prepared in line with the regulatory and documentation requirements of the destination market.
Quality systems built for regulated markets.
From formulation to final dispatch, our manufacturing discipline is designed to meet the expectations of licensed healthcare partners and export regulators alike.
Pharmacopoeial precision
Every formulation is manufactured and released against USP/BP monograph specifications, with full batch identity, sterility, and potency documentation.
Aseptic, GMP-aligned processing
Our injectable and oral lines are produced under controlled aseptic conditions consistent with WHO-GMP guidelines, from raw material intake to final release.
Full batch traceability
Every carton carries batch number, manufacturing and expiry dates, and full manufacturer documentation — traceable from formulation to final dispatch.
Export-ready compliance
Recognised as a government export house, we structure documentation and logistics around the regulatory requirements of the destination market.
Independently recognised quality and compliance.
Have a requirement? Let's talk.
Reach our export and business development team directly for MOQ, documentation, and licensing queries — no account or checkout required.